20
Participants
Start Date
October 8, 2019
Primary Completion Date
December 23, 2019
Study Completion Date
December 23, 2019
JNJ-64417184
Participants will receive single dose of JNJ-64417184 as oral tablet.
PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini, Groningen
Janssen Research & Development, LLC
INDUSTRY